The biggest stories of the day delivered to your inbox.

A research team led by The Hong Kong University of Science and Technology (HKUST) scholars has discovered a significant slowdown in Arctic sea ice melting since 2012, with a decrease rate of 11.3% per ...

The MarketWatch News Department was not involved in the creation of this content. Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene ...

At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA) vaccine designed to help prevent triple-negative breast cancer (TNBC), ...

It’s been non-stop. Relentless North Atlantic swells have marched across the ocean and bludgeoned coastline across the Continent’s Western Flank – and looking at the long-range forecast, this is not ...

Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for investigational therapy pumitamig (BNT327/BMS986545) plus ...

At the beginning of this season, Jonathan Kuminga’s relationship with the Golden State Warriors appeared to be skyrocketing, but it turns out the trajectory was more like a boomerang. Kuminga did not ...

NEW YORK, NEW YORK - OCTOBER 08: Traders work on the floor of the New York Stock Exchange during morning trading on October 08, 2024 in New York City. Stocks opened up on the rise after the Dow Jones ...

Trodelvy reduced risk of disease progression or death versus chemotherapy in patients with previously untreated metastatic triple-negative breast cancer. Treatment with Trodelvy (Sacituzumab govitecan ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...

Gabe Vincent gestures to a Lakers teammate after hitting a 3-pointer in a preseason game against the Mavericks. Candice Ward / Getty Images No NBA franchise played more preseason games than the Los ...

German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative symptoms of schizophrenia met its primary endpoint. Data ...